>
Switch to:

Bio-Techne Revenue per Share

: $22.98 (TTM As of Jun. 2021)
View and export this data going back to 1992. Start your Free Trial

Bio-Techne's revenue per share for the three months ended in Jun. 2021 was $6.32. Bio-Techne's revenue per share for the trailing twelve months (TTM) ended in Jun. 2021 was $22.98.

Good Sign:

Bio-Techne Corp has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue Per Share Growth Rate of Bio-Techne was 22.70% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 10.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 10.40% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Bio-Techne's Revenue per Share or its related term are showing as below:

NAS:TECH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 5.3   Med: 12.5   Max: 23
Current: 10.8

5.3
23

During the past 13 years, Bio-Techne's highest 3-Year average Revenue Per Share Growth Rate was 23.00% per year. The lowest was 5.30% per year. And the median was 12.50% per year.

NAS:TECH's 3-Year Revenue Growth Rate is ranked higher than
71% of the 190 Companies
in the Biotechnology industry.

( Industry Median: -14.95 vs. NAS:TECH: 10.80 )

Bio-Techne Revenue per Share Historical Data

The historical data trend for Bio-Techne's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Revenue per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.01 16.90 18.36 18.75 23.00

Bio-Techne Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Revenue per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.45 5.10 5.57 5.99 6.32

Bio-Techne Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Bio-Techne's Revenue Per Share for the fiscal year that ended in Jun. 2021 is calculated as

Revenue Per Share (A: Jun. 2021 )=Revenue (A: Jun. 2021 )/Shares Outstanding (Diluted Average) (A: Jun. 2021 )
=931.032/40.483
=23.00

Bio-Techne's Revenue Per Share for the quarter that ended in Jun. 2021 is calculated as

Revenue Per Share (Q: Jun. 2021 )=Revenue (Q: Jun. 2021 )/Shares Outstanding (Diluted Average) (Q: Jun. 2021 )
=259.028/41.017
=6.32

Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Techne  (NAS:TECH) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Bio-Techne Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Techne Business Description

Bio-Techne logo
Industry
Healthcare » Biotechnology NAICS : 325414 SIC : 2836
Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Executives
Hippel James officer: Chief Financial Officer 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Kummeth Charles R. director, officer: Chief Executive Officer 425 MARTINGALE ROAD SUITE 1000 SCHAUMBURG IL 60173-2213
Furlow Brenda S. officer: SVP - General Counsel 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Eansor Norman David officer: President-Protein Sciences 8100 SOUTHPARK WAY, A-8 LITTLETON CO 80120
Kelderman Kim officer: Pres. Diagnostics & Genom 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Bushman Julie L director 185 SOUTH 84TH STREET, SUITE 200 MILWAUKEE WI 53214
Wiens Harold J director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: WIENS HAROLD J a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Baumgartner Robert V director 5775 WAYZATA BOULEVARD, SUITE 400 MINNEAPOLIS MN 55416
Higgins John L director 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Nusse Roeland director 473 TENNESSEE PALO ALTO CA 94306
Keegan Joseph D director C/O MOLECULAR DEVICES CORP 1311 ORLEANS DRIVE SUNNYVALE CA 94089
Seth Alpna director 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Steer Randolph C director 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Vessey Rupert director C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Dinarello Charles A director 333 15TH STREET BOULDER CO 80302

Bio-Techne Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)